{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:14:18Z","timestamp":1761844458468},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T00:00:00Z","timestamp":1428710400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13104-015-1065-4","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T20:58:55Z","timestamp":1428613135000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Familial partial lipodystrophy, Dunnigan variety - challenges for patient care during pregnancy: a case report"],"prefix":"10.1186","volume":"8","author":[{"given":"Sandra Patr\u00edcia Mota","family":"Belo","sequence":"first","affiliation":[]},{"given":"\u00c2ngela Celeste","family":"Magalh\u00e3es","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Freitas","sequence":"additional","affiliation":[]},{"given":"Davide Maur\u00edcio","family":"Carvalho","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,4,11]]},"reference":[{"key":"1065_CR1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S1043-2760(00)00309-X","volume":"11","author":"ML Reitman","year":"2000","unstructured":"Reitman ML, Arioglu E, Gavrilova O, Taylor SI. Lipoatrophy revisited. Trends Endocrinol Metab. 2000;11:410\u20136.","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"1065_CR2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/jhg.2013.107","volume":"59","author":"T Nolis","year":"2014","unstructured":"Nolis T. Exploring the pathophysiology behind the more common genetic and acquired lipodystrophies. J Hum Genet. 2014;59(1):16\u201323.","journal-title":"J Hum Genet"},{"key":"1065_CR3","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","volume":"350","author":"A Garg","year":"2004","unstructured":"Garg A. Acquired and inherited lipodystrophies. N Engl J Med. 2004;350:1220\u201334.","journal-title":"N Engl J Med"},{"key":"1065_CR4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbalip.2008.12.014","volume":"1791","author":"A Garg","year":"2009","unstructured":"Garg A, Agarwal AK. Lipodystrophies: disorders of adipose tissue biology. Biochim Biophys Acta. 2009;1791:507\u201313.","journal-title":"Biochim Biophys Acta"},{"key":"1065_CR5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ecl.2004.03.003","volume":"33","author":"A Garg","year":"2004","unstructured":"Garg A, Misra A. Lipodystrophies: rare disorders causing metabolic syndrome. Endocrinol Metab Clin North Am. 2004;33:305\u201331.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1065_CR6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.med.57.022605.114424","volume":"57","author":"AK Agarwal","year":"2006","unstructured":"Agarwal AK, Garg A. Genetic basis of lipodystrophies and management of metabolic complications. Annu Rev Med. 2006;57:297\u2013311.","journal-title":"Annu Rev Med"},{"key":"1065_CR7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng585","volume":"28","author":"J Magre","year":"2001","unstructured":"Magre J, Delepine M, Khallouf E, Gedde-Dahl Jr T, Van Maldergem L, Sobel E, et al. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet. 2001;28:365\u201370.","journal-title":"Nat Genet"},{"key":"1065_CR8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng880","volume":"31","author":"AK Agarwal","year":"2002","unstructured":"Agarwal AK, Arioglu E, De Almeida S, Akkoc N, Taylor SI, Bowcock AM, et al. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat Genet. 2002;31:21\u20133.","journal-title":"Nat Genet"},{"key":"1065_CR9","first-page":"408","volume":"87","author":"AK Agarwal","year":"2002","unstructured":"Agarwal AK, Garg A. A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy. J Clin Endocrinol Metab. 2002;87:408\u201311.","journal-title":"J Clin Endocrinol Metab"},{"key":"1065_CR10","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.2337\/diabetes.51.12.3586","volume":"51","author":"RA Hegele","year":"2002","unstructured":"Hegele RA, Cao H, Frankowski C, Mathews ST, Leff T. PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy. Diabetes. 2002;51:3586\u201390.","journal-title":"Diabetes"},{"key":"1065_CR11","doi-asserted-by":"crossref","first-page":"910","DOI":"10.2337\/diabetes.52.4.910","volume":"52","author":"DB Savage","year":"2003","unstructured":"Savage DB, Tan GD, Acerini CL, Jebb SA, Agostini M, Gurnell M, et al. Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma. Diabetes. 2003;52:910\u20137.","journal-title":"Diabetes"},{"key":"1065_CR12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/hmg\/9.1.109","volume":"9","author":"H Cao","year":"2000","unstructured":"Cao H, Hegele RA. Nuclear lamin A\/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet. 2000;9:109\u201312.","journal-title":"Hum Mol Genet"},{"key":"1065_CR13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/72807","volume":"24","author":"S Shackleton","year":"2000","unstructured":"Shackleton S, Lloyd DJ, Jackson SN, Evans R, Niermeijer MF, Singh BM, et al. LMNA, encoding lamin A\/C, is mutated in partial lipodystrophy. Nat Genet. 2000;24:153\u20136.","journal-title":"Nat Genet"},{"key":"1065_CR14","first-page":"3431","volume":"85","author":"RA Hegele","year":"2000","unstructured":"Hegele RA, Cao H, Anderson CM, Hramiak IM. Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy. J Clin Endocrinol Metab. 2000;85:3431\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"1065_CR15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrm1550","volume":"6","author":"Y Gruenbaum","year":"2005","unstructured":"Gruenbaum Y, Margalit A, Goldman RD, Shumaker DK, Wilson KL. The nuclear lamina comes of age. Nat Rev Mol Cell Biol. 2005;6:21\u201331.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1065_CR16","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/323560a0","volume":"323","author":"U Aebi","year":"1986","unstructured":"Aebi U, Cohn J, Buhle L, Gerace L. The nuclear lamina is a meshwork of intermediate-type filaments. Nature. 1986;323:560\u20134.","journal-title":"Nature"},{"key":"1065_CR17","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.ijo.0802487","volume":"28","author":"AK Agarwal","year":"2004","unstructured":"Agarwal AK, Barnes RI, Garg A. Genetic basis of congenital generalized lipodystrophy. Int J Obes Relat Metab Disord. 2004;28:336\u20139.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"1065_CR18","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/hmg\/ddi480","volume":"15","author":"RL Boguslavsky","year":"2006","unstructured":"Boguslavsky RL, Stewart CL, Worman HJ. Nuclear lamin A inhibits adipocyte differentiation: implications for Dunnigan-type familial partial lipodystrophy. Hum Mol Genet. 2006;15:653\u201363.","journal-title":"Hum Mol Genet"},{"key":"1065_CR19","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/sj.cdd.4402197","volume":"14","author":"M Caron","year":"2007","unstructured":"Caron M, Auclair M, Donadille B, Bereziat V, Guerci B, Laville M, et al. Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence. Cell Death Differ. 2007;14:1759\u201367.","journal-title":"Cell Death Differ"},{"key":"1065_CR20","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.2337\/diacare.26.5.1350","volume":"26","author":"WA Haque","year":"2003","unstructured":"Haque WA, Oral EA, Dietz K, Bowcock AM, Agarwal AK, Garg A. Risk factors for diabetes in familial partial lipodystrophy, Dunnigan variety. Diabetes Care. 2003;26:1350\u20135.","journal-title":"Diabetes Care"},{"key":"1065_CR21","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/ng0398-292","volume":"18","author":"JM Peters","year":"1998","unstructured":"Peters JM, Barnes R, Bennett L, Gitomer WM, Bowcock AM, Garg A. Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22. Nat Genet. 1998;18:292\u20135.","journal-title":"Nat Genet"},{"key":"1065_CR22","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/302836","volume":"66","author":"RA Speckman","year":"2000","unstructured":"Speckman RA, Garg A, Du F, Bennett L, Veile R, Arioglu E, et al. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A\/C. Am J Hum Genet. 2000;66:1192\u20138.","journal-title":"Am J Hum Genet"},{"key":"1065_CR23","first-page":"59","volume":"86","author":"A Garg","year":"2001","unstructured":"Garg A, Vinaitheerthan M, Weatherall PT, Bowcock AM. Phenotypic heterogeneity in patients with familial partial lipodystrophy (dunnigan variety) related to the site of missense mutations in lamin a\/c gene. J Clin Endocrinol Metab. 2001;86:59\u201365.","journal-title":"J Clin Endocrinol Metab"},{"key":"1065_CR24","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00125-004-1360-4","volume":"47","author":"DB Savage","year":"2004","unstructured":"Savage DB, Soos MA, Powlson A, O\u2019Rahilly S, McFarlane I, Halsall DJ, et al. Familial partial lipodystrophy associated with compound heterozygosity for novel mutations in the LMNA gene. Diabetologia. 2004;47:753\u20136.","journal-title":"Diabetologia"},{"key":"1065_CR25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.5603\/EP.2013.0010","volume":"64","author":"K Nabrdalik","year":"2013","unstructured":"Nabrdalik K, Strozik A, Minkina-Pedras M, Jarosz-Chobot P, Mlynarski W, Grzeszczak W, et al. Dunnigan-type familial partial lipodystrophy associated with the heterozygous R482W mutation in LMNA gene - case study of three women from one family. Endokrynol Pol. 2013;64:306\u201311.","journal-title":"Endokrynol Pol"},{"key":"1065_CR26","first-page":"170","volume":"84","author":"A Garg","year":"1999","unstructured":"Garg A, Peshock RM, Fleckenstein JL. Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety). J Clin Endocrinol Metab. 1999;84:170\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"1065_CR27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1464-5491.2009.02909.x","volume":"27","author":"A Ludtke","year":"2010","unstructured":"Ludtke A, Roos GM, van Hettinga M, Horst BA, Worman HJ, Schmidt HH. Post-mortem findings in Dunnigan-type familial partial lipodystrophy. Diabet Med. 2010;27:245\u20136.","journal-title":"Diabet Med"},{"key":"1065_CR28","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1111\/j.1572-0241.2005.00234.x","volume":"100","author":"A Ludtke","year":"2005","unstructured":"Ludtke A, Genschel J, Brabant G, Bauditz J, Taupitz M, Koch M, et al. Hepatic steatosis in Dunnigan-type familial partial lipodystrophy. Am J Gastroenterol. 2005;100:2218\u201324.","journal-title":"Am J Gastroenterol"},{"key":"1065_CR29","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1212\/01.wnl.0000255939.73424.f8","volume":"68","author":"S Spuler","year":"2007","unstructured":"Spuler S, Kalbhenn T, Zabojszcza J, van Landeghem FK, Ludtke A, Wenzel K, et al. Muscle and nerve pathology in Dunnigan familial partial lipodystrophy. Neurology. 2007;68:677\u201383.","journal-title":"Neurology"},{"key":"1065_CR30","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.2337\/diabetes.49.11.1958","volume":"49","author":"C Vigouroux","year":"2000","unstructured":"Vigouroux C, Magre J, Vantyghem MC, Bourut C, Lascols O, Shackleton S, et al. Lamin A\/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy. Diabetes. 2000;49:1958\u201362.","journal-title":"Diabetes"},{"key":"1065_CR31","first-page":"1776","volume":"85","author":"A Garg","year":"2000","unstructured":"Garg A. Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety). J Clin Endocrinol Metab. 2000;85:1776\u201382.","journal-title":"J Clin Endocrinol Metab"},{"key":"1065_CR32","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1210\/jc.2007-2521","volume":"93","author":"MC Vantyghem","year":"2008","unstructured":"Vantyghem MC, Vincent-Desplanques D, Defrance-Faivre F, Capeau J, Fermon C, Valat AS, et al. Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy. J Clin Endocrinol Metab. 2008;93:2223\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"1065_CR33","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1530\/EJE-12-0268","volume":"167","author":"PB Mory","year":"2012","unstructured":"Mory PB, Crispim F, Freire MB, Salles JE, Valerio CM, Godoy-Matos AF, et al. Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations. Eur J Endocrinol. 2012;167:423\u201331.","journal-title":"Eur J Endocrinol"},{"key":"1065_CR34","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1210\/jc.2007-0654","volume":"92","author":"A Decaudain","year":"2007","unstructured":"Decaudain A, Vantyghem MC, Guerci B, Hecart AC, Auclair M, Reznik Y, et al. New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome. J Clin Endocrinol Metab. 2007;92:4835\u201344.","journal-title":"J Clin Endocrinol Metab"},{"key":"1065_CR35","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1590\/S0004-27302013000800002","volume":"57","author":"D Caldas","year":"2013","unstructured":"Caldas D, Silva Junior WS, Simonetti JP, Costa EV, Farias ML. [Biochemical, hormonal and genetic evaluation of the families of two Brazilian patients with type 2 familial partial lipodystrophy]. Arq Bras Endocrinol Metabol. 2013;57:583\u201393.","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"1065_CR36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000320166","volume":"1","author":"B Saha","year":"2010","unstructured":"Saha B, Lessel D, Hisama FM, Leistritz DF, Friedrich K, Martin GM, et al. A novel LMNA mutation causes altered nuclear morphology and symptoms of familial partial lipodystrophy (dunnigan variety) with progeroid features. Mol Syndromology. 2010;1:127\u201332.","journal-title":"Mol Syndromology"},{"key":"1065_CR37","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1042\/BST20110675","volume":"39","author":"G Bidault","year":"2011","unstructured":"Bidault G, Vatier C, Capeau J, Vigouroux C, Bereziat V. LMNA-linked lipodystrophies: from altered fat distribution to cellular alterations. Biochem Soc Trans. 2011;39:1752\u20137.","journal-title":"Biochem Soc Trans"},{"key":"1065_CR38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.diabet.2009.01.001","volume":"35","author":"C Collet-Gaudillat","year":"2009","unstructured":"Collet-Gaudillat C, Billon-Bancel A, Beressi JP. Long-term improvement of metabolic control with pioglitazone in a woman with diabetes mellitus related to Dunnigan syndrome: a case report. Diabetes Metab. 2009;35:151\u20134.","journal-title":"Diabetes Metab"},{"key":"1065_CR39","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.diabet.2007.04.005","volume":"33","author":"F Moreau","year":"2007","unstructured":"Moreau F, Boullu-Sanchis S, Vigouroux C, Lucescu C, Lascols O, Sapin R, et al. Efficacy of pioglitazone in familial partial lipodystrophy of the Dunnigan type: a case report. Diabetes Metab. 2007;33:385\u20139.","journal-title":"Diabetes Metab"},{"key":"1065_CR40","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","volume":"346","author":"EA Oral","year":"2002","unstructured":"Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med. 2002;346:570\u20138.","journal-title":"N Engl J Med"},{"key":"1065_CR41","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.metabol.2006.11.010","volume":"56","author":"JY Park","year":"2007","unstructured":"Park JY, Javor ED, Cochran EK, DePaoli AM, Gorden P. Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy. Metabolism. 2007;56:508\u201316.","journal-title":"Metabolism"},{"key":"1065_CR42","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1210\/jc.2011-2229","volume":"97","author":"V Simha","year":"2012","unstructured":"Simha V, Subramanyam L, Szczepaniak L, Quittner C, Adams-Huet B, Snell P, et al. Comparison of efficacy and safety of leptin replacement therapy in moderately and severely hypoleptinemic patients with familial partial lipodystrophy of the Dunnigan variety. J Clin Endocrinol Metab. 2012;97:785\u201392.","journal-title":"J Clin Endocrinol Metab"},{"key":"1065_CR43","first-page":"A5482","volume":"157","author":"IM Jazet","year":"2013","unstructured":"Jazet IM, Jonker JT, Wijngaarden MA, Lamb H, Smelt AH. [Therapy resistant diabetes mellitus and lipodystrophy: leptin therapy leads to improvement]. Ned Tijdschr Geneeskd. 2013;157:A5482.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"1065_CR44","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI0215001","volume":"109","author":"KF Petersen","year":"2002","unstructured":"Petersen KF, Oral EA, Dufour S, Befroy D, Ariyan C, Yu C, et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest. 2002;109:1345\u201350.","journal-title":"J Clin Invest"},{"key":"1065_CR45","first-page":"50","volume":"23","author":"T Morrow","year":"2014","unstructured":"Morrow T. Myalept approved for treatment of disorders marked by loss of body fat. Manag Care. 2014;23:50\u20131.","journal-title":"Manag Care"},{"key":"1065_CR46","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4158\/EP11229.OR","volume":"17","author":"JL Chan","year":"2011","unstructured":"Chan JL, Lutz K, Cochran E, Huang W, Peters Y, Weyer C, et al. Clinical effects of long-term metreleptin treatment in patients with lipodystrophy. Endocr Pract. 2011;17:922\u201332.","journal-title":"Endocr Pract"},{"key":"1065_CR47","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000242614","volume":"50","author":"RH Knopp","year":"1986","unstructured":"Knopp RH, Warth MR, Charles D, Childs M, Li JR, Mabuchi H, et al. Lipoprotein metabolism in pregnancy, fat transport to the fetus, and the effects of diabetes. Biol Neonate. 1986;50:297\u2013317.","journal-title":"Biol Neonate"},{"key":"1065_CR48","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/jog.12095","volume":"39","author":"S Sato","year":"2013","unstructured":"Sato S, Ohkuchi A, Kawano M, Iwanaga N, Furukawa Y, Matsumoto H. Effect of eicosapentaenoic acid agent on aggravated hypertriglyceridemia during pregnancy. J Obstet Gynaecol Res. 2013;39:1541\u20134.","journal-title":"J Obstet Gynaecol Res"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-015-1065-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13104-015-1065-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-015-1065-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T02:04:29Z","timestamp":1566525869000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1756-0500\/8\/140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,11]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1065"],"URL":"https:\/\/doi.org\/10.1186\/s13104-015-1065-4","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,11]]},"article-number":"140"}}